{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:58:27Z","timestamp":1785859107493,"version":"3.56.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,27]]},"DOI":"10.1097\/qad.0b013e328351f662","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T04:36:27Z","timestamp":1332477387000},"page":"776-778","source":"Crossref","is-referenced-by-count":7,"title":["Drug interactions between voriconazole, darunavir\/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia"],"prefix":"10.1097","volume":"26","author":[{"given":"Manel","family":"Aouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent A.","family":"Decosterd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Calmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Livio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/QAD.0b013e32834403cd","article-title":"Drug interactions between voriconazole, darunavirritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.","volume":"25","author":"Toy","year":"2011","journal-title":"AIDS"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1128\/AAC.00404-10","article-title":"Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole N-oxide, anidulafungin and caspofungin.","volume":"54","author":"Decosterd","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jchromb.2009.02.057","article-title":"A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: raltegravir, maraviroc, darunavir and etravirine.","volume":"877","author":"Fayet","year":"2009","journal-title":"J Chromatograph B Analyt Technol Biomed Life Sci"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.2008.168","article-title":"Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure.","volume":"85","author":"Mathias","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R5-17-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/11584570-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir.","volume":"50","author":"Ramanathan","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/AAC.00526-07","article-title":"Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.","volume":"51","author":"Liu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1345\/aph.1K530","article-title":"Complexity of interactions between voriconazole and antiretroviral agents.","volume":"42","author":"Yakiwchuk","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2125.2008.03191.x","article-title":"Pharmacokinetics of darunavirritonavir and ketoconazole following co-administration in HIV- healthy volunteers.","volume":"66","author":"Sekar","year":"2008","journal-title":"Br J Clin Pharmacol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006416-201203000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:51Z","timestamp":1785855951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201203270-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328351f662","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}